Clinical trial
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
NCT00316745 · Hokkaido Gastrointestinal Cancer Study Group, Other · Suspended
Key facts
| NCT number | NCT00316745 |
|---|---|
| Title | IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer |
| Official title | Irinotecan Combined With S-1( IRIS ) Followed by mFOLFOX6 Regimen Versus mFOLFOX6 Followed by IRIS Regimen in Advanced Colorectal Cancer |
| Lead sponsor | Hokkaido Gastrointestinal Cancer Study Group, Other |
| Collaborators | Hokkaido University Hospital |
| Status | Suspended |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Metastatic Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Campto, Topotesin, TS-1, L-Plat, Isovorin, 5-FU |
| Enrollment | 200 |
| Start date | Apr 1, 2006 |
| Completion | Mar 1, 2009 |
| First posted | Apr 21, 2006 |
| Last update posted | Nov 1, 2007 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: